Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ 320,740	$ 42	$ 432,703	$ (1,535)	$ (110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Exercise of common stock options	1,580		1,580
Exercise of common stock options (in shares)		148,649
Vesting of restricted shares	134		134
Vesting of restricted shares (in shares)		37,898
Stock-based compensation	5,473		5,473
Unrealized gain (loss) on available-for-sale securities, net	796			796
Net loss	(17,459)				(17,459)
Ending balance at Mar. 31, 2023	311,264	$ 42	439,890	(739)	(127,929)
Ending balance (in shares) at Mar. 31, 2023		41,802,807
Beginning balance at Dec. 31, 2023	344,349	$ 46	512,401	665	(168,763)
Beginning balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	320,076	$ 5	320,071
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		5,397,301
Exercise of common stock options	$ 1,657		1,657
Exercise of common stock options (in shares)	186,282	186,282
Vesting of restricted shares	$ 5		5
Vesting of restricted shares (in shares)		4,548
Stock-based compensation	5,625		5,625
Unrealized gain (loss) on available-for-sale securities, net	(1,189)			(1,189)
Net loss	(14,760)				(14,760)
Ending balance at Mar. 31, 2024	$ 655,763	$ 51	$ 839,759	$ (524)	$ (183,523)
Ending balance (in shares) at Mar. 31, 2024		51,840,571